Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbidopa in Familial Dysautonomia
NCT02553265Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Sep 2015
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbidopa + levodopa in Familial dysautonomia (FD), sponsored by NYU Langone Health. Started Sep 2015; status: completed.
02
Drugs
carbidopa + levodopa
03
Conditions
Familial dysautonomia (FD)
Beyond the preview
Go deeper on NCT02553265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02553265.